149 related articles for article (PubMed ID: 11210963)
21. Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines.
Han EK; Gehrke L; Tahir SK; Credo RB; Cherian SP; Sham H; Rosenberg SH; Ng S
Eur J Cancer; 2000 Aug; 36(12):1565-71. PubMed ID: 10930805
[TBL] [Abstract][Full Text] [Related]
22. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
Karantanis E; Nicholson S; Morris DL
Eur J Surg Oncol; 1994 Dec; 20(6):653-7. PubMed ID: 7995417
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Hari M; Loganzo F; Annable T; Tan X; Musto S; Morilla DB; Nettles JH; Snyder JP; Greenberger LM
Mol Cancer Ther; 2006 Feb; 5(2):270-8. PubMed ID: 16505100
[TBL] [Abstract][Full Text] [Related]
24. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
Parekh H; Wiesen K; Simpkins H
Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
[TBL] [Abstract][Full Text] [Related]
25. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-18-S10-21. PubMed ID: 9275002
[TBL] [Abstract][Full Text] [Related]
27. Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines.
Liu B; Staren E; Iwamura T; Appert H; Howard J
World J Gastroenterol; 2001 Dec; 7(6):855-9. PubMed ID: 11854916
[TBL] [Abstract][Full Text] [Related]
28. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
29. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
[TBL] [Abstract][Full Text] [Related]
32. Effects of Taxotere on murine and human tumor cell lines.
Riou JF; Naudin A; Lavelle F
Biochem Biophys Res Commun; 1992 Aug; 187(1):164-70. PubMed ID: 1381586
[TBL] [Abstract][Full Text] [Related]
33. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
[TBL] [Abstract][Full Text] [Related]
34. The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol.
Li L; Jiang AC; Dong P; Wan Y; Yu ZW
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):659-64. PubMed ID: 17903587
[TBL] [Abstract][Full Text] [Related]
35. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.
Wils P; Phung-Ba V; Warnery A; Lechardeur D; Raeissi S; Hidalgo IJ; Scherman D
Biochem Pharmacol; 1994 Oct; 48(7):1528-30. PubMed ID: 7945455
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
Tanaka M; Obata T; Sasaki T
Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
[TBL] [Abstract][Full Text] [Related]
37. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
38. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.
Liu B; Staren E; Iwamura T; Appert H; Howard J
World J Gastroenterol; 2001 Feb; 7(1):143-8. PubMed ID: 11819752
[No Abstract] [Full Text] [Related]
39. Taxoids in combination chemotherapy for metastatic breast cancer.
Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
[TBL] [Abstract][Full Text] [Related]
40. Treatment of patients resistant to paclitaxel therapy.
Valero V
Anticancer Drugs; 1996 Aug; 7 Suppl 2():17-9. PubMed ID: 8862705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
